Literature DB >> 25308768

COPD is associated with cognitive dysfunction and poor physical fitness in heart failure.

Michael L Alosco1, Mary Beth Spitznagel2, Richard Josephson3, Joel Hughes2, John Gunstad4.   

Abstract

OBJECTIVE: To examine the associations among chronic obstructive pulmonary disease (COPD), cognitive function, and physical fitness in heart failure (HF).
BACKGROUND: Cognitive impairment in HF in part stems from medical comorbidities and poor physical fitness. COPD, a frequent co-existing condition in HF, is a risk factor for cognitive impairment and a known cause of poor physical fitness. Yet, the interplay among COPD, cognition, and physical fitness has never been examined in HF.
METHODS: 191 HF patients completed a cognitive test battery and brief physical fitness assessment. Diagnostic history of COPD was ascertained via medical chart review.
RESULTS: Regression analyses showed HF patients with COPD exhibited worse attention/executive function and poorer fitness relative to their non-COPD counterparts. Worse fitness correlated with cognitive dysfunction.
CONCLUSIONS: COPD is associated with reduced cognition and worse fitness in HF. Longitudinal work that employs objective assessments of COPD is needed to determine directionality and clarify mechanisms.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; Cognitive function; Heart failure; Physical fitness

Mesh:

Year:  2014        PMID: 25308768      PMCID: PMC4267965          DOI: 10.1016/j.hrtlng.2014.09.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  33 in total

1.  Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery.

Authors:  S S Dikmen; R K Heaton; I Grant; N R Temkin
Journal:  J Int Neuropsychol Soc       Date:  1999-05       Impact factor: 2.892

2.  Evaluating dementia screening tests: methodologic standards to rate their performance.

Authors:  D R Gifford; J L Cummings
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

3.  Improvement of cognitive function after a three-month pulmonary rehabilitation program for COPD patients.

Authors:  Eanes D B Pereira; Cinthya Sampaio Viana; Tauily C E Taunay; Penha U Sales; Jose W O Lima; Marcelo A Holanda
Journal:  Lung       Date:  2011-06-09       Impact factor: 2.584

Review 4.  Obesity as a risk factor for poor neurocognitive outcomes in older adults with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; John Gunstad
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates.

Authors:  John A Schinka; David A Loewenstein; Ashok Raj; Mike R Schoenberg; Jessica L Banko; Huntington Potter; Ranjan Duara
Journal:  Am J Geriatr Psychiatry       Date:  2010-08       Impact factor: 4.105

7.  Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.

Authors:  J M Burns; B B Cronk; H S Anderson; J E Donnelly; G P Thomas; A Harsha; W M Brooks; R H Swerdlow
Journal:  Neurology       Date:  2008-07-15       Impact factor: 9.910

8.  Depression is associated with reduced physical activity in persons with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Lindsay Miller; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Donna Waechter; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Health Psychol       Date:  2012-08-27       Impact factor: 4.267

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

Review 10.  Improving physical activity in COPD: towards a new paradigm.

Authors:  Thierry Troosters; Thys van der Molen; Michael Polkey; Roberto A Rabinovich; Ioannis Vogiatzis; Idelle Weisman; Karoly Kulich
Journal:  Respir Res       Date:  2013-10-30
View more
  7 in total

1.  Predictors of medication nonadherence differ among black and white patients with heart failure.

Authors:  Victoria Vaughan Dickson; George J Knafl; Barbara Riegel
Journal:  Res Nurs Health       Date:  2015-05-11       Impact factor: 2.228

2.  Reduced Attention in Former Smokers with and without COPD.

Authors:  Anna Croghan; Amanda Brunette; Kristen E Holm; Elizabeth Kozora; David J Moser; Frederick S Wamboldt; Kimberly Meschede; Barry J Make; James D Crapo; Howard D Weinberger; Kerrie L Moreau; Russell P Bowler; Karin F Hoth
Journal:  Int J Behav Med       Date:  2019-12

Review 3.  Cognitive Dysfunction in Heart Failure: Pathophysiology and Implications for Patient Management.

Authors:  Sylvia Ye; Quan Huynh; Elizabeth L Potter
Journal:  Curr Heart Fail Rep       Date:  2022-08-13

Review 4.  Cognitive decline in heart failure.

Authors:  Kannayiram Alagiakrishnan; Darren Mah; Ali Ahmed; Justin Ezekowitz
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

5.  Cognition and Exercise: GENERAL OVERVIEW AND IMPLICATIONS FOR CARDIAC REHABILITATION.

Authors:  Diann E Gaalema; Katharine Mahoney; Jacob S Ballon
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-11-01       Impact factor: 2.081

6.  Quality of life among patients with cardiac disease: the impact of comorbid depression.

Authors:  Mandreker Bahall; George Legall; Katija Khan
Journal:  Health Qual Life Outcomes       Date:  2020-06-17       Impact factor: 3.186

7.  Self-management of heart failure in dementia and cognitive impairment: a systematic review.

Authors:  Janaka Lovell; Tony Pham; Samer Q Noaman; Marie-Claire Davis; Marilyn Johnson; Joseph E Ibrahim
Journal:  BMC Cardiovasc Disord       Date:  2019-04-29       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.